VAXIGRIP
VAXIGRIP
Discontinued
DIN Number
02367718
Drug Class
Human
Market Date
Sep 16, 2011
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02367718
AIG Number0324197003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
HAEMAGGLUTININ-STRAIN A (H1N1)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H1N1)
HAEMAGGLUTININ-STRAIN A (H3N2)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H3N2)
HAEMAGGLUTININ-STRAIN BActive
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN B